Peginterferon alfa-2b plus ribavirin for chronic hepatitis [8] (multiple letters)

Lancet

Volumn 359, Issue 9302, 2002, Pages 263-264

  Santin, Miguel ^a   Shaw, Evelyn ^a   Picon, Paulo D ^b   Costa, Andry F ^b   Kuchenbecker, Ricardo ^b   Beltrame, Alberto ^b   Cecil, Bennet D ^c   Manns, Michael P ^d   McHutchison, John ^d   Koury, Kenneth ^d   Albrecht, Janice K ^d  

^a HOSPITAL CLÍNIC   (Spain)

^b MINISTÉRIO DA SAÚDE   (Brazil)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; PEGINTERFERON ALFA-2B; PEGINTERFERON ALPHA2A;

AGE; CHRONIC HEPATITIS; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG INDICATION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; VIRUS LOAD; DRUG COMBINATION; HEPATITIS C; NOTE; BODY WEIGHT; VIROLOGY;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; POLYETHYLENE GLYCOLS; RIBAVIRIN; BODY WEIGHT;

EID: 0037132841     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(02)07428-7     Document Type: Letter

References (3)

1. Manns MP McHutchinson JG Gordon SC Peginterferon alfa-2b plus ribavarin compared with interferon alfa-2b plus ribavarin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958 965
2. Cecil B Individualized antiviral therapy using viral kinetics for hepatitis C patients Louisville Med 49 2001 83 84
3. Cecil B, Lavelle M. Individualized hepatitis C therapy of military veterans: interferon dose escalation improves the sustained viral response rate, presented at AASLD, Dallas, TX, 2001.